Future Virology最新文献

筛选
英文 中文
Effects of COVID-19 and vaccination on the human immune system: cases of lymphopenia and autoimmunity 新冠肺炎和疫苗接种对人体免疫系统的影响:淋巴细胞减少和自身免疫病例
IF 3.1 4区 医学
Future Virology Pub Date : 2023-04-01 DOI: 10.2217/fvl-2022-0218
Joachim Gerlach, A. Baig
{"title":"Effects of COVID-19 and vaccination on the human immune system: cases of lymphopenia and autoimmunity","authors":"Joachim Gerlach, A. Baig","doi":"10.2217/fvl-2022-0218","DOIUrl":"https://doi.org/10.2217/fvl-2022-0218","url":null,"abstract":"","PeriodicalId":12505,"journal":{"name":"Future Virology","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43879156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conference proceedings from hybrid 25th Bangkok International Symposium on HIV Medicine 第25届曼谷艾滋病毒医学国际混合研讨会会议记录
IF 3.1 4区 医学
Future Virology Pub Date : 2023-03-28 DOI: 10.2217/fvl-2023-0019
P. Ohata, A. Avihingsanon, Siwat Thammapiwan, W. M. Han, Akarin Hiransuthikul, Hay Mar Su Lwin, S. Ubolyam, Jedsadakorn Boonrungsirisap, S. Kerr, S. Gatechompol, T. Puthanakit, O. Putcharoen, K. Ruxrungtham, P. Phanuphak
{"title":"Conference proceedings from hybrid 25th Bangkok International Symposium on HIV Medicine","authors":"P. Ohata, A. Avihingsanon, Siwat Thammapiwan, W. M. Han, Akarin Hiransuthikul, Hay Mar Su Lwin, S. Ubolyam, Jedsadakorn Boonrungsirisap, S. Kerr, S. Gatechompol, T. Puthanakit, O. Putcharoen, K. Ruxrungtham, P. Phanuphak","doi":"10.2217/fvl-2023-0019","DOIUrl":"https://doi.org/10.2217/fvl-2023-0019","url":null,"abstract":"The Bangkok International Symposium on HIV Medicine has commenced on the 3rd Wednesday in January since 1998. The Symposium aims to provide professional healthcare workers in Thailand and the region an opportunity to receive the most up-to-date information on HIV and its related conditions if they are unable to attend other HIV conferences abroad. This year’s hybrid symposium was held from 18 January to 20 January 2023. A total of six plenary sessions were held in the mornings, and four afternoon workshops held on Wednesday and Thursday. Expert speakers from Thailand, China, Malaysia, Singapore, India, Hong Kong, Philippines, Australia, UK, The Netherlands and the USA participated in the symposium.","PeriodicalId":12505,"journal":{"name":"Future Virology","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2023-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43240772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RT-LAMP is a potential future molecular diagnostic tool for influenza A virus RT-LAMP是一种潜在的a型流感病毒分子诊断工具
IF 3.1 4区 医学
Future Virology Pub Date : 2023-03-15 DOI: 10.2217/fvl-2022-0136
Sanjit Boora, Anishkumar Khan, Vikrant Sharma, S. Kaushik, P. Mehta, S. Singh, S. Kaushik
{"title":"RT-LAMP is a potential future molecular diagnostic tool for influenza A virus","authors":"Sanjit Boora, Anishkumar Khan, Vikrant Sharma, S. Kaushik, P. Mehta, S. Singh, S. Kaushik","doi":"10.2217/fvl-2022-0136","DOIUrl":"https://doi.org/10.2217/fvl-2022-0136","url":null,"abstract":"Aim: Influenza A virus (IAV) causes serious illness and is responsible for significant morbidity and mortality. To diagnose IAV infection in its early stages, a quick, sensitive, precise detection method is needed for effective clinical management. Materials & methods: In-house hydroxylnaphthol blue (HNB)-based RT-LAMP assay for early detection of IAV using the HA gene was compared with RT-PCR/multiplex-RT-PCR. Results: For the reference strains of IAV, (H1N1 (A/Texas/50/2012) and H3N2 (A/Malaysia/2089302/2009)) RT-LAMP and RT-PCR/M-RT-PCR exhibited a limit of detection (LOD) of 10 and 100 fg/ml, respectively. Conclusion: HNB-based RT-LAMP is a rapid, sensitive, cost-effective diagnostic tool, and could be a point-of-care test for IAV patients during outbreaks.","PeriodicalId":12505,"journal":{"name":"Future Virology","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2023-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47896372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Potential roles of core and core+1 proteins during the chronic phase of hepatitis C virus infection 核心蛋白和核心+1蛋白在丙型肝炎病毒感染慢性期的潜在作用
IF 3.1 4区 医学
Future Virology Pub Date : 2023-03-14 DOI: 10.2217/fvl-2022-0117
Asra Malekshahi, A. Alamdary, Ali Safarzadeh, A. Khavandegar, H. R. Nikoo, Mahshid Safavi, Mobina Ajorloo, Atefeh Bahavar, Mehdi Ajorloo
{"title":"Potential roles of core and core+1 proteins during the chronic phase of hepatitis C virus infection","authors":"Asra Malekshahi, A. Alamdary, Ali Safarzadeh, A. Khavandegar, H. R. Nikoo, Mahshid Safavi, Mobina Ajorloo, Atefeh Bahavar, Mehdi Ajorloo","doi":"10.2217/fvl-2022-0117","DOIUrl":"https://doi.org/10.2217/fvl-2022-0117","url":null,"abstract":"The HCV Core protein is a multifunctional protein that interacts with many viral and cellular proteins. In addition to the encapsidation of the viral genome, it can disturb various cellular pathways and impede antiviral cellular responses such as interferon (IFN) production. The Core protein can also disrupt the functions of immune cells against HCV. The Core protein helps viral infection persistency by interfering with apoptosis. The Core+1 protein plays a significant role in inducing chronic HCV infection through diverse mechanisms. We review some of the mechanisms by which Core and Core+1 proteins facilitate HCV infection to chronic infection. These proteins could be considered for designing more sufficient treatments and effective vaccines against HCV.","PeriodicalId":12505,"journal":{"name":"Future Virology","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2023-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46569306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nanocarrier-based drug delivery system in herpes simplex virus treatment 纳米载体给药系统在单纯疱疹病毒治疗中的应用
IF 3.1 4区 医学
Future Virology Pub Date : 2023-03-09 DOI: 10.2217/fvl-2022-0171
W. Yin, Liqiong Ding
{"title":"Nanocarrier-based drug delivery system in herpes simplex virus treatment","authors":"W. Yin, Liqiong Ding","doi":"10.2217/fvl-2022-0171","DOIUrl":"https://doi.org/10.2217/fvl-2022-0171","url":null,"abstract":"Herpes simplex virus (HSV) is a highly contagious DNA virus that affects the majority of people worldwide. HSV establishes a latent infection in the ganglia, where it can reactivate, leading to recurrent disease. Currently, there are many experimental vaccines against HSV, but none have been used to treat herpes infections. At the same time, the therapeutic effect of existing anti-HSV drugs is limited. Nanocarriers, which deliver drugs to specific targets, have been used in different diseases, including viral infections. Nanocarriers could be designed to encapsulate drugs and directly target infected cells. This review will describe in detail the use of nanocarriers for targeted therapy of HSV infection.","PeriodicalId":12505,"journal":{"name":"Future Virology","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2023-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42220984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiological and clinical features of human rabies in Dazu District, Chongqing, China from 2014 to 2021 2014 - 2021年重庆市大足区人狂犬病流行病学及临床特征
IF 3.1 4区 医学
Future Virology Pub Date : 2023-03-06 DOI: 10.2217/fvl-2022-0149
Wan Shi-Gang, Liu He-Lei, Xia Hong, Wu Jing
{"title":"Epidemiological and clinical features of human rabies in Dazu District, Chongqing, China from 2014 to 2021","authors":"Wan Shi-Gang, Liu He-Lei, Xia Hong, Wu Jing","doi":"10.2217/fvl-2022-0149","DOIUrl":"https://doi.org/10.2217/fvl-2022-0149","url":null,"abstract":"The epidemiological and clinical data of human rabies cases in the Dazu District of Chongqing from 2014 to 2021 were analyzed retrospectively to determine the epidemiological and clinical features of human rabies cases in Chonqing, China. Nine cases were reported. All cases occurred in farmers from rural areas associated with lower rabies awareness, and eight cases had a definitive history of animal exposure, most commonly in the form of domestic dog bites. All nine patients presented as manic and died within 1–8 days from disease onset (mortality rate of 100%). Increased public awareness of rabies prevention and control is needed, especially among middle-aged and elderly populations in rural areas.","PeriodicalId":12505,"journal":{"name":"Future Virology","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2023-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49236943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Torque teno virus and cancers: current knowledge 扭力病毒和癌症:目前的知识
IF 3.1 4区 医学
Future Virology Pub Date : 2023-03-06 DOI: 10.2217/fvl-2022-0111
A. Lasagna, A. Piralla, S. Borgetto, M. Quaccini, F. Baldanti, P. Pedrazzoli
{"title":"Torque teno virus and cancers: current knowledge","authors":"A. Lasagna, A. Piralla, S. Borgetto, M. Quaccini, F. Baldanti, P. Pedrazzoli","doi":"10.2217/fvl-2022-0111","DOIUrl":"https://doi.org/10.2217/fvl-2022-0111","url":null,"abstract":"Aim: The aim of this systematic review is to assess the current knowledge about the relationship between Torque teno virus (TTV) and cancer in different settings. Methods: A systematic search was conducted in Medline via PubMed, Embase and Cochrane Library from the inception to the end of January 2023. Results: 34 articles were included in the qualitative synthesis of this review and 2145 patients with solid tumors have been analyzed. The most prevalent cancer types were hepatocellular carcinoma (HCC) and lung cancer. Conclusion: TTV has proven its role as a marker of functional immune competence in the setting of hematopoietic stem cell transplantation (HSCT), but in the oncological field is yet to be defined.","PeriodicalId":12505,"journal":{"name":"Future Virology","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2023-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43515061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plasma cytokine profile in occult HBV-infected blood donors 隐匿性乙型肝炎病毒感染献血者的血浆细胞因子谱
IF 3.1 4区 医学
Future Virology Pub Date : 2023-03-03 DOI: 10.2217/fvl-2022-0193
Qinghui Wang, Huizhong Qian, Xiao Liu, Jian Jiang, Qingqin Hao
{"title":"Plasma cytokine profile in occult HBV-infected blood donors","authors":"Qinghui Wang, Huizhong Qian, Xiao Liu, Jian Jiang, Qingqin Hao","doi":"10.2217/fvl-2022-0193","DOIUrl":"https://doi.org/10.2217/fvl-2022-0193","url":null,"abstract":"Aim: Cytokine profile in occult HBV infection (OBI) was systematically investigated to identify the immunopathogenesis of OBI. Materials & methods: A total of 46 OBI, ten asymptomatic hepatitis B surface antigen carriers, ten chronic hepatitis B and 12 healthy blood donors were recruited. A total of 21 plasma cytokines were detected. Results: Compared with healthy blood donors, elevated plasma Th1, Th2, Th17 and immune regulatory associated cytokines were observed in OBI. Almost no significant difference was found for these cytokines among OBI, asymptomatic hepatitis B surface antigen carriers and chronic hepatitis B. OBI displayed the predominance of type 2 and regulatory immunity. Conclusion: OBI displayed the general cytokine profile of chronic HBV infection, which might contribute to virus persistence and the presence of the liver microinflammatory environment. The clinical implications of OBI deserve more attention.","PeriodicalId":12505,"journal":{"name":"Future Virology","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2023-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48602181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recombinant Newcastle disease virus kills liver cancer in vitro and in vivo 重组新城疫病毒在体外和体内杀死肝癌
IF 3.1 4区 医学
Future Virology Pub Date : 2023-03-03 DOI: 10.2217/fvl-2022-0183
Ding Yang, Shunli Guo, Yisen Feng, Dandan Wu, Yapei Li, Zhouyangfan Peng, Sufang Zhou
{"title":"Recombinant Newcastle disease virus kills liver cancer in vitro and in vivo","authors":"Ding Yang, Shunli Guo, Yisen Feng, Dandan Wu, Yapei Li, Zhouyangfan Peng, Sufang Zhou","doi":"10.2217/fvl-2022-0183","DOIUrl":"https://doi.org/10.2217/fvl-2022-0183","url":null,"abstract":"Aim: To construct and rescue a recombinant Newcastle disease virus that can express IP10 protein and evaluate its targeted killing effect on liver cancer in vivo and in vitro. Materials & methods: Fluorescence quantitative PCR, western blot and ELISA were used to detect the expression and secretion of IP10 in cells. The H22 mouse liver cancer cells were used to establish subcutaneous tumor-bearing mice experimental animal tumor models, and the tumor growth of mice in each group was observed while receiving treatment with rLasota. Results: The recombinant Newcastle disease virus was successfully constructed and can kill tumor cells successfully. Conclusion: The rLasota-IP10-IRES-EGFP achieves antitumor effects by killing hepatocellular carcinoma cells, enhancing T-lymphocyte infiltration in tumor tissues and inhibiting neovascularization.","PeriodicalId":12505,"journal":{"name":"Future Virology","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2023-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45217624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
DPP-4 Inhibitors as a savior for COVID-19 patients with diabetes. DPP-4抑制剂作为COVID-19糖尿病患者的救星
IF 3.1 4区 医学
Future Virology Pub Date : 2023-03-01 DOI: 10.2217/fvl-2022-0112
Snehasish Nag, Samanwita Mandal, Oindrila Mukherjee, Suprabhat Mukherjee, Rakesh Kundu
{"title":"DPP-4 Inhibitors as a savior for COVID-19 patients with diabetes.","authors":"Snehasish Nag,&nbsp;Samanwita Mandal,&nbsp;Oindrila Mukherjee,&nbsp;Suprabhat Mukherjee,&nbsp;Rakesh Kundu","doi":"10.2217/fvl-2022-0112","DOIUrl":"https://doi.org/10.2217/fvl-2022-0112","url":null,"abstract":"<p><p>Diabetic patients are at particular risk of severe COVID-19. Human dipeptidyl peptidase-4 (DPP-4) is a membrane-bound aminopeptidase that regulates insulin release by inactivating incretin. DPP-4 inhibitors (DPP-4is) are therefore used as oral anti-diabetic drugs to restore normal insulin levels. These molecules also have anti-inflammatory and anti-hypertension effects. Recent studies on the interactions of SARS-CoV-2 spike glycoprotein and DPP-4 predict a possible entry route for SARS-CoV-2. Therefore, DPP-4is could be effective at reducing the virus-induced 'cytokine storm', thereby ceasing inflammatory injury to vital organs. Moreover, DPP-4is may interfere with viral entry into host cells. Herein, we have reviewed the efficacy of DPP-4is as potential repurposed drugs to reduce the severity of SARS-CoV-2 infection in patients with diabetes.</p>","PeriodicalId":12505,"journal":{"name":"Future Virology","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10096336/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9321832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信